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1 Introduction  24 
The applications of natural products are widespread in food, cosmetics, perfumes and 25 
pharmaceutical industries. Many natural products are also used in textiles to improve the textures 26 
of fibrous materials for multipurpose applications. Chitosan (deacetylated chitin) is such a 27 
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product, typically found in exoskeletons of arthropods and crustaceans and also in fungal cell 28 
walls. It is a polycationic polysaccaride compound which has a tendency to interact with other 29 
chemicals resulting in various novel morphologies of microcapsules. The rigid chemical 30 
structure of chitosan makes it suitable in forming films, gels and microcapsules. Moreover, its 31 
biological, chemical and physical properties make it viable for developing the microcapsules 32 
containing active ingredients [1].  33 
A microcapsule comprises of a core and a shell matrix, the core contains active ingredient 34 
whereas the shell is either a polymeric or a waxy material. The preparation of microcapsules 35 
depends on various parameters such as solubility, viscosity and the emulsification behaviour of 36 
the reaction mixture. Once applied on a desirable site, the active ingredients are inclined to be 37 
released under controlled conditions. The shell behaves as a transferring channel to the target 38 
where it releases the active ingredients which in turn depend on the material used for the shell 39 
formation including its specific end uses [2]. Microencapsulation allows the control release of 40 
the active ingredient for deposition at targeted site under specific conditions to carry out the 41 
required functionality. Any external chemical, physical or mechanical stimulant can be applied 42 
on microcapsule to tune the controlled release of active ingredient. 43 
Chitosan coated microcapsules are used for the protection of active ingredients from external 44 
factors such as temperature and pH variations. Different types of core materials such as active 45 
pharmaceutical ingredients, food products, catalysts, oils and pigments can be microencapsulated 46 
using chitosan as shell material [3]. Chemically, chitosan contains free amine groups either in 47 
neutral or basic media whereas protonated amines are formed in acidic media. This pH sensitive 48 
feature makes the chitosan based compounds suitable in controlled release technologies [4]. 49 
Chitosan microcapsules containing drugs as an active ingredient allow their slow release under 50 
specific conditions at the targeted sites in the body. For example, lipophilic drugs were 51 
encapsulated in chitosan to be effectively released latterly in the intestinal tract of the human 52 
body [5]. Similarly, chitosan microencapsulation of vaccines allows their delivery and controlled 53 
release on the targeted sites. Fish, neem seed and other essential oils had also been 54 
microencapsulated in chitosan to limit their rate of oxidation [6]. Chitosan chains can be cross-55 
linked with glutaraldehyde or citric acid for astaxanthin microencapsulation to increase its 56 
antioxidant potential [7]. Chitosan encapsulation of quercetin flavonoids has also been reported 57 
to allow their control release targeted as an inflammation therapy [8]. 58 
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The applications of chitosan microencapsulation are widespread in biomedical, cosmetics, 59 
agriculture, food and textile. In this review, we have discussed chitosan chemistry and recent 60 
advances made in the previous few years in chitosan microencapsulation process, and various 61 
conditions and parameters used for the selection of core and shell materials which effect the 62 
encapsulation process.  63 
We have presented current researches concerned with encapsulating various active ingredients in 64 
chitosan polymer and its derivatives and discussed the role of chitosan in enhancing the 65 
functional properties of active ingredient. Several examples of chitosan microencapsulation of 66 
various active ingredients with different chemical nature have been analysed which demonstrate 67 
the wider scope of chitosan for microencapsulation for various applications like biomedical, 68 
tissue engineering, pharmaceutical, food industry, textile, agriculture and the environment. In 69 
addition, this review also provides an insight in to recent advancement in encapsulation 70 
techniques based on their advantages and disadvantages.  71 
1.1 Chitosan formation  72 
Chitosan is a linear polysaccharide of [(1→4)-β-linked 2-amino-2-deoxy-d-glucose] that is 73 
slightly hydrophilic in nature. Crabs, shrimps and some other crustaceans’ shells contain chitin 74 
(β-(1→4)-N-acetyl-d-glucosamine) which upon reacting with alkaline sodium hydroxide give an 75 
N-deacetylation product, known as chitosan [9]. The process of deacetylation of chitin to 76 
produce chitosan is presented in Fig. 1.  77 
Please insert Fig. 1 here… 78 
Some basic properties of chitosan have been listed in Table 1 which must be considered while 79 
working for various applications. Chitosan has been considered a versatile biopolymer that can 80 
be amended using various approaches to improve its physiochemical properties thus making it 81 
suitable for several desirable applications. Some of biological properties of chitosan along with 82 
its applications have been summarized in Table 2, which represents its wide scope of potential 83 
applications in various fields. Furthermore, chitosan has also proven itself an excellent 84 
biopolymer shell material for the encapsulation of several active ingredients which have been 85 
presented in the following text. 86 
Please insert Table 1 here… 87 
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Please insert Table 2 here… 88 
2 Microencapsulation 89 
Generally, microencapsulation involves the formation of minute capsules which entrap some 90 
active ingredient under some specific conditions and releasing them under other suitable 91 
conditions. The encapsulation of active ingredients can be improved by rendering liquids into 92 
powders and preventing their clumping which results in protecting active ingredients from 93 
oxidation, heat, acidity, alkalinity, moisture or evaporation. It also prevents them from reacting 94 
with unwanted species which may induce degradation or polymerization in the system. 95 
Encapsulation can also be used for masking unpleasant odour; improving handling of ingredients 96 
before processing; releasing active material in controlled manners and finally protecting workers 97 
from exposure to toxins [10].  98 
The products of microencapsulation are microparticles, microcapsules and microspheres as 99 
shown in Fig. 2. They can be differentiated based on their morphology and internal structure. 100 
Microcapsules contain active ingredients surrounded by shells while the microspheres are the 101 
matrixes containing active ingredients dispersed inside them. Microparticles vary their size in 102 
range from 100 to 1000 nm. Capsules with 1 to 1000 μm diameter are termed as microcapsules 103 
[11]. A microcapsule is comprised of two parts; a core and a shell.  104 
The individual particles droplets or liquid materials are typical examples of cores whereas the 105 
surrounding coat prepared from different polymeric materials are typical examples of shells. 106 
Further, shell materials include polymers, fats, waxes and carbohydrates. Their selection mainly 107 
depends on the nature of the core material and the applications of the microcapsule. 108 
Microencapsulation is, therefore, a way to protect the core material from temperature, moisture 109 
and microorganisms which may otherwise cause harmful effects to the  active ingredients inside 110 
them [12]. Different approaches are used for microencapsulation as shown in Table 3. 111 
Please insert Fig. 2 here… 112 
Please insert Table 3 here… 113 
The selection of a suitable microencapsulation approach depends on the nature and physico-114 
chemical properties of the encapsulated material. The core material of microcapsule may be an 115 
adsorbent particle, suspension of solid or an emulsion [13]. It should be inaccessible to the 116 
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surrounding media from unwanted chemical to prevent its deterioration [14]. The encapsulating 117 
agents are very important for the microcapsules’ stability and efficiency. The criterion for the 118 
selection of the encapsulating material depends upon its properties such as compatibility of the 119 
shell materials, the structure of the encapsulating agents and the economic and processing 120 
aspects involved. One type of a microencapsulating agent may not have all the required 121 
properties; therefore, combinations of different microencapsulating agents can be adopted for 122 
better production of microcapsules. The choice of an encapsulating agent also depends on the 123 
toxicity level, stability, efficiency, protection degree and microscopic properties of the produced 124 
micro-particles [12]. 125 
2.1 Controlling the morphology of microcapsules 126 
There are three different morphologies of microcapsules which include mononuclear, 127 
polynuclear and matrix encapsulation as shown in Fig. 2. The mononuclear microcapsules 128 
comprise of shell material surrounding the core material whereas the polynuclear microcapsules 129 
contain a shell material surrounding several cores. The matrix encapsulation involves the fine 130 
dispersion of core material into the shell material. The basic structures for microcapsule may also 131 
contain mononuclear core with multiple shells or microcapsules clusters [15]. The morphology 132 
of microcapsules depends on the nature and composition of both core and shell materials and 133 
their mode of interaction. The morphology of microcapsules is typically controlled by existing 134 
conditions such as temperature, pH and the method used in their preparation. 135 
2.2 The selection of core and shell materials 136 
Core material can either be a liquid or solid coated with polymers, waxes, polysaccharides or 137 
proteins depending on the requirement of the produced microcapsule. The dispersed or dissolved 138 
materials are typically included in liquid cores whereas active constituents, stabilizers, diluents, 139 
excipients and release retardants or accelerators are included in the solid core. The varying 140 
composition of the core material provides flexible characteristics to develop the desired 141 
properties in a microcapsule. The specific coating/shell on the surface of core material provide 142 
suitable physical and chemical properties to the microcapsules. This coating material on the 143 
surface of core material should be chemically non-reactive so as not to alter the chemical 144 
composition of the core material. The desired properties are achieved in the coating material 145 
such as flexibility, impermeability, strength, stability and optical properties etc. [16]. 146 
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The selection of coating material is a very important step in the encapsulation process because it 147 
may have decisive effect on the functional properties of the final encapsulated product. To 148 
ensure true encapsulation, the stability of microcapsules, prolong storage abilities, suitable drug 149 
release mechanism and resistance against the harsh environment , the following factors should be 150 
considered in the selection of  core and shell material [17]: 151 
• Solubility of core material, 152 
• Physical state of the core material (either liquid or solid), 153 
• Core reactivity with solvent and wall material, 154 
• Desired size of microcapsule, 155 
• Method for attachment of core to the shell material, 156 
• Release properties of the core material from the microcapsule, and 157 
• The economics of the process and product.  158 
For instance, Ying and co-workers [18] reported the development of chitosan spherical particles 159 
in which poly (n-butyl acrylate) was encapsulated as an active ingredient. The pad-dry-cure 160 
method was used to apply the microcapsules on cotton fabric. Antibacterial activities of the 161 
microcapsules were reported to be excellent with up to 99% reduction of bacterial growth. Folate 162 
conjugated pluronic chitosan was studied for drug delivery of doxorubicin to cancerous cells. 163 
The pluronic micelle containing doxorubicin acted as a core material while the folate conjugated 164 
chitosan was used as shell material through some electrostatic interactions. The encapsulated 165 
material was effective in the treatment of tumour cells, mainly breast cancer cells in which folate 166 
receptors were successfully expressed [19].           167 
2.3 Microencapsulation process and release profile 168 
Microencapsulation approaches can be categorized into chemical, physical and mechanical 169 
techniques. Chemical microencapsulation is a versatile method for the encapsulation of drugs. It 170 
is further subdivided into complex coacervation, interfacial polymerization and in situ 171 
polymerization. The coacervation is a phase separation technique with two liquid phases. One 172 
phase is called as coacervation phase usually containing polymers while other do not have 173 
polymer. The process completes in three steps; in the first step, a polymer of oppositely charged 174 
precipitate and process is called complex coacervation. In second step, coacervate is deposited 175 
on the dispersed phase, containing active ingredients, and in the third step, the polymer film gets 176 
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hardened [10]. In the interfacial polymerization, a reactive polymer is dissolved in two 177 
immiscible liquids and the polymerization take place at the interface [20]; while in the in situ 178 
polymerization, solution of shell material is added into the core phase and the deposition of 179 
polymer of core material takes place by changes in the pH or temperate [21]. Some advantages 180 
and disadvantages of these techniques have been compared in Table 3. 181 
The microencapsulation process is generally divided into three major stages. In the first stage, 182 
some active constituents are incorporated into the matrix or the core of microcapsules which may 183 
be in the form of emulsions or suspensions. In the second stage, the liquid form of the matrix 184 
makes a dispersion and the solid matrix through spraying a solution under agitation. In the last 185 
stage, droplets are stabilized by different physicochemical approaches. The releasing mechanism 186 
of the core material depends upon the nature of stimulant and the morphology of microcapsules. 187 
The microencapsulation ensures the stabilization and immobilization of the active constituents 188 
whereas the coating permits different levels of release and protection [22]. A schematic process 189 
of a drug microencapsulation and its release profile have been shown in Fig. 3. 190 
Please insert Fig. 3 here… 191 
2.4 The conditions for microcapsules formation 192 
Many parameters or conditions should be considered while preparing microcapsules as their 193 
yield is greatly influenced by temperature and pH conditions. The following features may be 194 
considered to achieve efficient production of microcapsules [23]:  195 
• Size of particles, morphology of microcapsule, encapsulation efficiency and drug release rate 196 
may be affected by the ratio of active ingredient to encapsulating material. 197 
• For chitosan microcapsules preparation and agitation speed considerably affects the cross-198 
linking reaction and emulsification process. The agitation method and speed are affected by 199 
the intrinsic viscosity of chitosan aqueous solutions. Microcapsules yield may be maximum 200 
at higher agitation speeds ensuring proper homogenizing [24]. 201 
• The yield of microcapsules depends on the concentration of shell materials. The releasing 202 
behaviours of the core content depends on the ratio of core and shell materials. The 203 
concentration of shell material is directly related to microcapsule yield. 204 
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• The microcapsule shell strength and surface adhesion properties are influenced by cross-205 
linking time and the yield. In short time, chitosan polymer may not completely cross-linked 206 
with the linking agent producing low yield [25]. 207 
Various studies have been conducted to investigate the effect of the above-mentioned parameter 208 
on chitosan encapsulation efficiency. For instance, some researchers [26] had encapsulated 209 
cortex moutan (a drug for hypertension treatment) in chitosan and investigated the effect of 210 
chitosan concentration on its encapsulating efficiency, it was observed that when the chitosan 211 
concentration was increased from 2 to 6% (w/v) its encapsulating efficiency increased 212 
significantly. They concluded that when the concentration of shell material increased the 213 
diffusion of drug decrease, accordingly. While studying the effect of ratio of active ingredient to 214 
encapsulating material, Devi and co-workers [27] observed that when ratio of core to shell 215 
material decreased form 1/50 to 1/300, the encapsulation efficient increased significantly. 216 
Kapadnis and co-workers [28] investigated the effect of degree of deacetylation of chitosan on 217 
the encapsulation of bovine serum albumin (BSA). They observed that BSA was efficiently 218 
encapsulated at high degree of deacetylation due to a higher number of functional groups on 219 
chitosan which increased its encapsulation efficiency. Han and co-workers [29] studied the effect 220 
of agitation speed (500, 800 and 1100 rpm) on the yield percentage of microcapsule. They 221 
observed maximum yield of 1100 rpm, when cortex moutan was homogenously mixed in 222 
chitosan solution for efficient encapsulation. 223 
2.5  Specific examples of chitosan microencapsulation 224 
Chitosan is the second most abundant natural biopolymer after cellulose and it has several amino 225 
and hydroxyl functional groups [30]. Due to the presence of positive charge on its amino groups, 226 
chitosan is the only commercially available water-soluble cationic polymer so far [31]. 227 
Furthermore, chitosan is pH sensitive due to the presence of D-glucosamine in its structure. 228 
These unique properties make chitosan an important shell material to entrap various active 229 
ingredients suitable for several applications in different fields. Many drugs can be encapsulated 230 
for targeted delivery approaches. Active food ingredients can also be encapsulated to protect 231 
them from microbial attack and to enhance their nutritional value. Chitosan can also be used to 232 
encapsulate vitamins for their applications in foods, cosmetotextiles and pharmaceutical industry. 233 
Chitosan encapsulation of essential oils, lipids, hemoglobin, astaxanthin and quercetin has found 234 
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diverse applications [32, 33]. Some specific examples of chitosan encapsulation of various active 235 
ingredients are illustrated below. 236 
2.6 Chitosan encapsulation of essential oils 237 
Essential oils can be used as antimicrobial agents however they are not widely used due to their 238 
volatility. Chitosan encapsulation is important for the slow release of essential oil ensuring the  239 
increased duration of oil availability to the required target [34]. Some researchers suggested that 240 
the essential oil of pimento was encapsulated into chitosan microspheres and chitosan/k-241 
carrageenan microspheres, separately [35]. The pad-dry-cure method was used to incorporate 242 
fabricated microcapsule on the cotton fabric using dihydroxy ethylene urea as a cross linker. 243 
Essential oils were encapsulated into chitosan microsphere (as shown in Fig. 4) to investigate 244 
their releasing property with chitosan/k-carrageenan microspheres. Chitosan microcapsule 245 
showed an effective release of the essential oil to control fungal and bacterial growth in 246 
comparison to chitosan/k-carrageenan microspheres [36]. Therein, FTIR and SEM confirmed the 247 
cross-linking within microcapsules. The concentration of chitosan and essential oil had 248 
determined the extent of antibacterial activity. The stiffness increased at higher concentration of 249 
chitosan and was decreased on increasing the essential oil concentration [37].  250 
Please insert Fig. 4 here…  251 
2.7 Chitosan encapsulation of neem seed oil  252 
Neem seed oil (NSO) extract is effectively used to control insects and pests on plants however 253 
due to their garlic or sulphur like odour, its use is limited in cosmetics and medicine products. 254 
The microspheres of NSO in a polyelectrolyte complex of chitosan and carrageenan had been 255 
prepared using complex coacervation as shown in Fig 5. The surface of the microcapsules 256 
became irregular as more oil was encapsulated inside them [6]. The burst release of NSO became 257 
more gradual on increasing the polymer concentration, the percentage of oil and the 258 
concentration of glutaraldehyde as crosslinking agent. The DSC analysis showed an absence of 259 
any interrelation and poor compatibility between the polyelectrolyte complex of chitosan and the 260 
carrageenan [38]. Chitosan and κ carrageenan were used to encapsulate NSO using three 261 
different cross-linkers (i.e., genipin, glutaraldehyde and tannic acid) to compare their effect on 262 
the release behaviour of the microcapsules. Therein, glutaraldehyde was found to be the best 263 
cross- linker to improve thermal stability, release behaviour and water uptake capacity of 264 
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chitosan microcapsules [39]. Both FTIR and the DSC analyses confirmed the absence of 265 
chemical interaction in microcapsules, but the release of NSO was entirely dependent on the 266 
cross-linker. The more the cross-linking agent used the less release of NSO occurred. I has 267 
therefore been concluded that microencapsulation of NSO can effectively be used as pesticides, 268 
insecticide and herbicide [40]. 269 
Please insert Fig. 5 here… 270 
2.8 Chitosan encapsulation of emulsified lipids 271 
Long-chain polyunsaturated omega-3 fatty acids, especially eicosapentaenoic acid (EPA, C20:5 272 
ω3) and docosahexaenoic acid (DHA, C22:6 ω3), are important to prevent cardiovascular 273 
disease, rheumatoid arthritis, diabetes, allergies and Alzheimer’s diseases [44]. The ability to 274 
microencapsulation of fish oils is therefore important to increase the nutritional value for such 275 
necessary food products. The stability and shelf life of fish oil and other bioactive and food 276 
components was improved by chitosan encapsulation preventing their auto-oxidation as 277 
compared to bulk storage. Such encapsulation had no significant effect on its in-vivo digestibility 278 
[41-43]. Therefore, some long-chain polyunsaturated omega-3 fatty acids isolated from fish oil 279 
were microencapsulated into chitosan shell using spray drying technique to reduce their 280 
susceptibility to ambient oxidation. The results showed enhanced stability and storage duration 281 
for these fish oil extract [44]. In a study, chitosan encapsulation of fish oil was also done using 282 
an ultrasonic atomizer through an emulsification method. As a result chitosan was not only 283 
capable to give a stable emulsion but its stability was enhanced with mediated with maltodextrin 284 
[45]. Likewise, milk originated shell materials had also been used to encapsulate fish oils using 285 
spray drying technique resulting in an increased encapsulation efficiency by increasing the 286 
temperature of inlet used for drying air to reduce moisture contents [46].  287 
2.9 Chitosan for α-lipoic acid encapsulation 288 
Chitosan had also been accepted as an effective method for α-lipoic acid (ALA) encapsulation. It 289 
prevents decomposition of ALA at elevated temperatures and provides an efficient delivery 290 
process. ALA was encapsulated in dry chitosan microbeads by swelling them in its respective 291 
solution. FTIR and differential scanning calorimetry (DSC) analyses revealed interaction of 292 
hydroxyl/amino groups of chitosan with the carboxylic acid groups of ALA. Its encapsulation 293 
efficiency was observed in the range from 46.8 to 58.5%. The retention of the non-extractable 294 
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ALA in the chitosan medium could deliver a continuous release of this antioxidant for a long 295 
period [47]. Liposomes containing coenzyme Q10 and ALA coated by chitosan were efficiently 296 
compared with uncoated liposomes. Hydrogen bonding and ionic interactions in chitosan-coated 297 
liposomes with ALA were enhanced showing effective radical scavenging capacity and sustained 298 
drug release behaviour [48]. The ALA-chitosan complex was formed showing ALA release due 299 
to changes in pH values. The ALA is used for energy production in the mitochondria acting as a 300 
cofactor. Its stability had been improved by chitosan encapsulation for safe release in the 301 
gastrointestinal tract [49]. The ALA had also been encapsulated in poly (ethylene oxide)/chitosan 302 
using single-capillary electrospray system. Excellent dispersity and stability of particles in 303 
suspension was observed under DLS based zeta potential measurements. The results 304 
demonstrated effective anti-inflammatory activity for poly(ethylene oxide)-chitosan coated ALA 305 
in comparison to free ALA solutions [50]. 306 
2.10 Chitosan encapsulation of drugs  307 
The efficiency of various pharmaceutical products could be improved by encapsulating the drugs 308 
into suitable shell materials. This does not only protect them from harsh external environment 309 
but also provide them with more effective properties and improve their bioactive roles in the 310 
human body. Controlled drugs release rate could be obtained from chitosan coated microspheres 311 
which might be suitable for oil soluble drugs. Among others approaches,  gelation and 312 
emulsification techniques had been considered excellent for intestinal delivery of lipophilic 313 
drugs due to improve their encapsulation efficiency [5].  314 
A microfluidic approach had been used to prepare double emulsion precursor for burst release of 315 
a hydrophobic drug coated with chitosan in acidic medium [51]. Chitosan is soluble in acid 316 
media while in neutral and basic media, chitosan microcapsules remain insoluble and maintain 317 
their morphologies. Thus, the microcapsules could decompose its shell in acidic media releasing 318 
their active ingredients making them suitable to target areas such as the stomach at pH<4. Any 319 
pH fluctuations greatly influence the properties of chitosan microcapsules [52]. Likewise, 320 
metronidazole is an antibiotic which is used to treat bacterial infection on skin, stomach and 321 
joints and is also used to treat inflammatory bowel disease [53]. It had been encapsulated in 322 
alginate beads mediated with different chitosan concentrations to develop some mucoadhesive 323 
properties. The encapsulation efficiency, surface morphology, swelling behaviour, and in vitro 324 
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and in vivo drug release profiles were assessed. Subsequently, it was observed that chitosan with 325 
high concentration showed efficient encapsulation and controlled drug release rate at pH 7.4 with 326 
extend exposure period [54].  327 
Tissue engineering helps improve the functions lost due to some pathological condition and 328 
damaged or diseased tissues [55]. Chitosan is an important material for tissue engineering and 329 
wound dressing application due to its biocompatibility [56]. Karpuraranjith and co-workers [57] 330 
had synthesized chitosan-g-β-cyclodextrin (chit-g- β-CD) scaffolds using freeze drying approach 331 
as active filling material during the treatment of damaged tissues. The β-CD made it efficient for 332 
drug loading as it improved the swelling behaviour of chitosan by decreasing its degree of 333 
hydrogen bonding.  Ketoprofen is a nonsteroidal anti-inflammatory drug which was encapsulated 334 
in chit-g-β-CD and its loading efficiency was observed to be increased at high concentration of 335 
chit-g-β-CD because β-CD increases the hydrophobic interaction with the ketoprofen molecules. 336 
The kinetic study showed that at initial stage, the drug release rate was high due to the presence 337 
of possible uncoated drug at the surface of shell. The drug release rate become slow and 338 
equilibrium was observed after 23 h. The slow release of the drug was due to complex formation 339 
between drug and the chit-g-β-CD. The nontoxic behaviour made it efficient for cross-linking of 340 
glutaraldehyde against the fibroblasts (L929) cells and the chit-g-β-CD; therefore, has become an 341 
important scaffold for tissue engineering applications. 342 
Chitosan is also used for non-viral gene delivery. Chitosan contains slightly positive charge in 343 
acidic media which allows the attachment of nucleic acids to the cationic chitosan. The DNA, 344 
siRNA and nanoparticles of nucleic acid could therefore be attached to chitosan for genes 345 
delivery [58]. However, its poor solubility in water makes it less efficient when compared with 346 
other synthetic cationic polymer such as polyethylenimine (PEI) and poly-L-lysine (PLL) [59]. 347 
Chitosan based nanoparticles could also be used for diagnostic purposes [60]. In a study, glycol 348 
chitosan (GC)-based nanoparticles were used to entrap the siRNA and chemotherapeutic drugs 349 
[61]. The encapsulation of doxorubicin (DOX) into chitosan formed DOX-CNPs whereas Bcl-2 350 
si-RNA formed some si-RNACNPs. The encapsulation of drugs with CNP gave similar in vivo 351 
distribution and chemical kinetics [62]. Some researchers suggested that chitosan encapsulated 352 
poly(lactic-co-glycolic acid NPs could be used for magnetic resonance (MR) imaging of cancer 353 
cells [63]. These nanoparticles were also encapsulated with paclitaxel for the treatment of cancer. 354 
Glycol CNPs interaction with 5β-cholanic acid was based on chemical modification to confirm 355 
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nano-carriers for drugs encapsulation which was efficient for tumour targeting. It was concluded 356 
that tumour-targeting ability was long lasting through the angiogenic vessels of tumour tissues. 357 
2.11 Chitosan for haemoglobin encapsulation  358 
Haemoglobin is an important constituent of blood carrying oxygen towards cells and tissues. For 359 
oral bioavailability of haemoglobin, encapsulation approach has been more efficient and protect 360 
it from desaturating at high temperatures and in organic solvents. The proposed process of 361 
haemoglobin encapsulation in chitosan is shown in Fig. 6. The microencapsulation was 362 
investigated to determine if it may increase the oxygen carrying capacity  and the in vitro 363 
releasing behaviour of haemoglobin [64]. Therein, freeze-dried bovine haemoglobin was 364 
encapsulated using chitosan or calcium alginate beads. The procedure was optimized for the 365 
formation of beads containing more than 90% of initial haemoglobin contents. The haemoglobin 366 
dissociates into its monomer and was released at pH 1.2 due to loss of interaction between 367 
negatively charged alginate and positively charged haemoglobin that exists at pH 5.5.  Globular 368 
proteins and cells could be encapsulated using this method [65].  369 
In another study alginate beads containing microencapsulated haemoglobin were coated with a 370 
dextran derivative for comparison between dextran and the chitosan. On changing the media pH 371 
from 3 to 4, the bonding interaction between beads and haemoglobin weakened ultimately 372 
releasing the haemoglobin. Dextran allowed slower haemoglobin release in comparison to 373 
chitosan [66]. The in vitro releasing behaviour of haemoglobin was evaluated using chitosan 374 
coating in three different conditions, namely uncoated, incomplete and completely coated 375 
microspheres. In the gastrointestinal tract, haemoglobin was quickly released from the uncoated 376 
and incomplete coated microspheres at pH 6.8 while the complete coating gave a slower release 377 
even at pH 1.2 [67]. The encapsulated haemoglobin affinity for oxygen binding was generally 378 
similar to that of the purified haemoglobin [64]. 379 
Please insert Fig. 6 here… 380 
2.12 Chitosan encapsulation of astaxanthin  381 
Astaxanthin is a ketocarotenoid belonging to the terpenes class with antioxidant potential of 100 382 
times greater than the β-tocopherol to protect skin against cancer and is used as anti-383 
inflammatory and immunostimulants agent [68]. It has been suggested that astaxanthin could be 384 
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encapsulated in chitosan to enhance its stability and to evaluate its isomerization at different 385 
temperatures [69]. A solvent evaporation method was used for the microencapsulation of 386 
astaxanthin in the chitosan using glutaraldehyde as a cross-linker. Microcapsules in powdered 387 
form were obtained with diameter in the range of 5-50 µm. The stability of these microcapsules 388 
was investigated under different storage conditions at temperatures 25, 35 and 45oC for 8 weeks. 389 
When the astaxanthin pigments were extracted from the chitosan microcapsules using a solvent 390 
mixture of methanol/dichloromethane to evaluate it using HPLC, it was observed that the 391 
microencapsulated astaxanthin was neither degraded nor isomerized. Kittikaiwan et al. [70] 392 
reported that Haematococcus pluvialis was used as a natural source of astaxanthin and was 393 
encapsulated in porous chitosan films (of 100 µm thickness) to evaluate its antioxidant activity. 394 
The chitosan coating prolonged the storage of astaxanthin with only 3% loss of antioxidant 395 
activity protecting against oxidative environment.  396 
2.13 Chitosan encapsulation of quercetin 397 
Quercetin is also an antioxidant, anti-inflammatory and anti-tumour agent found in apples, 398 
grapes and onions [71]. Quercetin was encapsulated to study its controlled release properties for 399 
desirable biological activities. Hao et al. [72] reported the use of spray-drying technique to obtain 400 
the microcapsules containing the flavonoid of quercetin. Chitosan had been used as suitable 401 
functional material for flavonoids microencapsulation to attain better resisting properties against 402 
harsh environment with desirable antioxidant activity under effective controlled release. 403 
Theoretically, flavonoids could efficiently entrap reactive oxygen species (ROS) due to their 404 
antioxidant potential [73]. 405 
Chitosan and xanthan gum were used within microencapsulated quercetin to ensure its controlled 406 
release in the colon for inflammation therapy [74]. Similarly, chitosan coated nano-liposomes 407 
containing quercetin proved its effectiveness in controlled release of quercetin giving enhanced 408 
stability and anti-proliferative activity and is therefore being considered as novel nanocapsules 409 
for the delivery of hydrophobic chemicals and storage of food products. The kinetic study 410 
showed that quercetin release delayed from the chitosan-based film when irradiated with an 411 
electron beam of 2.2 MeV energy. Such irradiation produced free radicals which helped cross-412 
linking between chitosan film and the quercetin which increased the stability of encapsulated 413 
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quercetin due to more linkage with the chitosan. This also prevented the burst release of core 414 
material from the biopolymeric matrix [75]. 415 
2.14 Chitosan encapsulation of vaccines 416 
Vaccines are important to protect body against pathogens and infectious diseases and their 417 
encapsulation is important to increase their immunogenicity. Jiao et al. [76] reported that a 418 
coacervation method was used to encapsulate diphtheria, tetanus toxoids and whole cell pertussis 419 
(DwPT) antigen using chitosan as shell material. Therein, vanillin was used as a cross-linker 420 
while sodium tripolyphosphate (STPP) as co-cross-linkers to develop the encapsulated vaccine. 421 
The encapsulated antigen in the chitosan microspheres exhibited mucoadhesive properties and 422 
controlled release of proteins which was suitable for oral vaccine development of the trivalent 423 
DwPT. For porcine nasal mucosa, chitosan coated poly(D,L lactic-co-glycolic acid) (PLGA) was 424 
investigated to compare its properties with Al(OH)3 coated PLGA. They observed that the tissue 425 
adhesion properties increased with the chitosan encapsulated PLGA via trans-cellular path acting 426 
as nasal vaccine carrier while Al(OH)3 encapsulated PLGA proved to be effective for tissue 427 
uptake, permeation and the adhesion for nasal mucosa cells. There also observed increased 428 
immunization using chitosan derivatives acting as a vaccine carrier [77]. The microspheres 429 
containing mannose had been used for improved DNA delivery into antigenic cells. 430 
Intramuscular injection was also used to deliver the vaccine in mice. The controlled release of 431 
DNA was observed with increased immunogenicity for chitosan microspheres proving to be a 432 
safer vaccination process for mice [78] . 433 
2.15 Chitosan encapsulation of vitamins  434 
The vitamin A, C, E and K are known as liposoluble compounds naturally found in food 435 
products. For pharmacological purposes, vitamins can be used to cure skin disease, cancer and 436 
the oxidative stress. Microencapsulation of vitamins may protect them from heat, light, oxygen 437 
and allows their slow release in order to prevent hypervitaminosis [79, 80]. Some details of 438 
selected vitamins encapsulation processes and subsequent effects are presented below. 439 
2.15.1 Chitosan encapsulation of vitamin C 440 
Vitamin C (ascorbic acid) is a water-soluble compound found in various foods and its deficiency 441 
causes scurvy and has diverse applications in the fields of biology, pharmacology and 442 
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dermatology. It helps strengthen the immune system and minimizes the risk of some severe 443 
diseases such as cancer, heart diseases and high lead (Pb) levels [78] . The human body can’t 444 
synthesize vitamin C or store it, therefore it must be taken through dietary nutrients, regularly. 445 
The sources of vitamin C include citrus fruits and green vegetables [81]. Vitamin C sensitivity 446 
towards pH, temperature and heat cause its spoilage in food therefore microencapsulation may 447 
help protect it from oxidative environments [78]. Spray drying technique has been used for 448 
encapsulating vitamin C (as shown in Fig. 7) because it causes minimum loss of ascorbic acid, 449 
both thermal phase separation and melt dispersion are effective for its release [82]. STPP was 450 
used as cross linker for encapsulation of vitamin C in double layered chitosan structure which 451 
proved effective for its controlled release in the gastric secretions and the intestinal fluids. It was 452 
observed that the encapsulation efficiency decreased on increasing the concentration of the 453 
crosslinking agent; this may be due to surface irregularities of chitosan. For control release and 454 
better encapsulating efficiency an appropriate amount of crosslinking agent should always be 455 
used [83] . 456 
Please insert Fig 7 here…. 457 
2.15.2 Chitosan encapsulation of Vitamin D 458 
Vitamin D exists in two main chemical forms; the first form is known as vitamin D3 or 459 
cholecalciferol while the second form is D2 ergocholecalciferol. The skin of the human body is 460 
able to synthesize vitamin D3 upon exposure to sunlight. Calciol, calcidiol and calcitriol are 461 
different forms of vitamin D3 which is important for bone metabolism, blood pressure, immunity, 462 
insulin secretion and homeostasis [84]. The second form D2 is present in food matrixes and can 463 
be released to form mixed micelles because it is lipophilic in nature. It enters in enterocytes, 464 
chylomicrons and the liver where it is activated for use as deficiency causes rickets, 465 
osteomalacia, fatigue and depression [85]. Carboxymethyl chitosan (CMCS) and soy protein 466 
isolate (SPI) complex nanoparticles had been studied to check the effect of Ca2+ concentration, 467 
pH and CMCS/SPI mass ratio. Vitamin D3 was encapsulated into CMCS/SPI polymeric 468 
complex. Lower concentration of Ca2+ was required for CMCS/SPI complex in comparison with 469 
CMCS for broad range of pH values. The encapsulation efficiency of the complex nanoparticles 470 
was high due to its compact structure. Vitamin D3 release was observed to be significantly higher 471 
under simulated intestinal conditions in comparison with gastric fluids. The use CMCS/SPI 472 
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complex nanoparticles were reported to be suitable for both encapsulation and controlled release 473 
of bioactive and hydrophobic nutraceuticals [86] . 474 
 Khan et al. [87]  reported that chitosan was used to coat the zein nanoparticles for encapsulation 475 
of vitamin D3. Uniform and true encapsulation was obtained on adding calcium source. The 476 
encapsulation efficiency obtained after coating with the addition of nanoparticles was 87.9%.  477 
Rabelo et al. [88] reported on a nanostructured lipid carriers (NLCs) coated with chitosan for 478 
encapsulation of vitamin D. The selection of lipid was based on higher encapsulation efficiency. 479 
Stearic acid (SA) and oleic acids (OA) were used in 70:30 (v/v) for the encapsulation of vitamin 480 
D due to their compatibility, stability and higher encapsulation efficiency. Chitosan coated NLCs 481 
showed excellent stability and storage without expulsion of vitamin D. It was concluded that a 482 
physically stable system was obtained after encapsulation of vitamin D.  Tan et al. [84] reported 483 
using chitosan to entrap vitamin D2 with ethyl cellulose coating via spray drying technique and 484 
was mainly used for controlled release of vitamin in intestinal juice for effective absorption. 485 
2.15.3 Chitosan microencapsulation of vitamin E  486 
Alpha tocopherol (vitamin E) is an environmental friendly dark viscous yellowish-brown oily 487 
substance with exceptional thermal stability and limited volatility [89]. Alpha tocopherol is 488 
important for food packaging to keep items afresh. It is present in different foods to protect lipids 489 
from auto oxidation and thus, increasing their shelf life. Its nature is hydrophobic and gives 490 
intense response in heat, oxygen and light. Its hydrophobicity minimize its applications in 491 
different fields of life [90].  It plays important role in the protection of skin from harmful UV-492 
light through absorption while giving antioxidant defence to the skin [91]. Both retinoic acid and 493 
alpha tocopherol are highly effective for dry skin but has limitations for use in cosmetics due to 494 
their sensitivity towards light and oxygen and some adverse reactions in localized areas such as 495 
erythema, xerosis and mild scaling. These problems could be controlled by their 496 
microencapsulation in chitosan shells, which protects from heat and light exposure. For topical 497 
applications, skin irritation can be minimized by incorporating retinoic acid and alpha tocopherol 498 
in chitosan microspheres. The stability and release time cam be increased for chitosan containing 499 
vitamins giving thermodynamically favourable applications [92] .  500 
The microencapsulation also protects the alpha tocopherol as a core material to regulate the 501 
delivery process [93]. The presence of polyunsaturated fatty acids in the biological membrane 502 
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makes them susceptible to oxidation by free radicals. Alpha tocopherol protects the membrane 503 
by converting the free radicals into stable species through their hydrogen bonding. The 504 
esterification process also gives stability to alpha-tocopherol but this molecule is at a risk of long 505 
term degradation [94]. Kaleem et al. [95] reported that the antioxidant activity of alpha-506 
tocopherol was dependent on their capability to give their alcoholic hydrogen to lipids. 507 
3. Chitosan based microcapsules applications 508 
Chitosan had found vast applications in the biomedical, textile, cosmetics, food and agriculture 509 
related industries. Chitosan is beneficial for wound dressing, gene delivery and tissue 510 
engineering, and treatment of acne, dermatitis and hair problems [96]. Chitosan have been used 511 
in encapsulating various food materials such as flavours, essential oils, vitamins, enzymes and 512 
aroma to protect them from degradation and control their release [97]. Chitosan has different 513 
environmental applications like remediation of inorganic and organic pollutants having toxic 514 
metals and dyes, traces of contaminants in soil and water bodies [98]. In recent days, chitosan 515 
has emerged as excellent biopolymer having potential applications in various fields such as drug 516 
functional additives, pharmaceuticals, agriculture and cosmetics [99]. 517 
Chitosan encapsulation may also improve the properties of encapsulated cosmetics and also 518 
provide protection from external adverse environment. Human skin glands excrete sebum which 519 
reacts with amino acids and the lactic acid of sweat to make skin surface mildly acidic at pH 5.5.  520 
The pH of most cosmetics has a range 5.5 to 7; therefore, these cosmetics must be encapsulated 521 
to allow the controlled release of different active agents. In drug delivery, chitosan is used as a 522 
coating material giving many advantages such as bio-adhesive properties, improvement and 523 
sustained drug release [100]. In a study investigating diclofenac release,  50% occurred within 524 
one hour when using uncoated microspheres while only 14.6% with the chitosan coated 525 
microparticles [101]. An exciting application of chitosan had been reported with calcium 526 
phosphate as a cementing agent where chitosan glycerophosphate combines with calcium 527 
phosphate and citric acid to form a self-hardening system for bone filling and repairing [102] .  528 
Chitosan membranes offer excellent permeability and high tensile strength making it suitable to 529 
use as an artificial kidney membrane [103]. The novel semipermeable membrane was established 530 
for better control of blood compatibility and transport materials. Patients who suffer from skin 531 
problems or severe infections and fluid loss, can be treated using chitosan capsule of novel 532 
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membrane [104]. These early symptoms require the rehabilitation and replacement of these skin 533 
problems by using chitosan membrane which acts as a biodegradable template for the synthesis 534 
of neodermal tissues. Chitosan polymer also has structural features that are similar to 535 
glycosamine glycans which can be considered for the development of substratum for skin 536 
replacement [104]. Chitosan microcapsules have great significance for the chromatographic 537 
supports. These spheres interact with the organic substances like lipids and proteins acting as 538 
electron donors for different metal ions [105]. 539 
Recently, chitosan has been used for the coagulation of suspended solid particles. According to 540 
the USA Environmental Protection Agency, chitosan is readily accepted for water applications 541 
[106]. The presence of chitosan in various fungi indicates that chitosan is already a part of 542 
human food. Different studies showed that chitosan is as safe as sugar and salt and can act as an 543 
active agent for food processing and biological activities such as hypocholersterolemic and 544 
hypolipidemic activities [107]. 545 
3.1 Specific applications in textiles 546 
Chitosan fibres are well known bio-functional fibres but other chitosan-based material such as 547 
bioyarns, biothreads and fragrant biofibres are not well known compared to chitosan fibres. 548 
Studies demonstrate that novel fragrant biofibre and yarn were prepared by Schiff base using 549 
fragrant aldehydes such as n-decylaldehyde [108]. A small portion of aldehyde was slowly 550 
released from the fibre and yarn in open air and a little amount was released in the dry close 551 
vessels [109]. Essential oils were microencapsulated into chitosan for different purposes for 552 
example citronella essential oil is volatile and when encapsulated into chitosan can be used as 553 
mosquito repellent on textile surface [110]. Other essential oils as linseed oil, lemon and oil 554 
phase change materials were also encapsulated into chitosan for their applications in the textile 555 
industry [111]. Chitosan encapsulation was also use for fragrance finishing on fabrics as it 556 
reduced their evaporation rate and increases their staying duration. Chitosan encapsulated rose 557 
fragrance forming nanoparticles by ionic gelification was applied on cotton fabrics [112]. 558 
Alpha (α)-tocopherol is an excellent antioxidant but under oxidizing conditions it show less 559 
stability which limit its applications. Raza and co-workers [113] encapsulated the alpha (α)-560 
tocopherol in chitosan nanospheres which enhanced its stability in oxidative environment and 561 
prolonged its control release. Chitosan encapsulated α-tocopherol application on cotton fabric 562 
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was investigated and it was observed that it causes little decrease in tensile strength while on the 563 
other hand increased its antibacterial efficiency.  564 
In another study, we also synthesized silver nanoparticles (SNPs) using chitosan polymer as 565 
stabilizing as well as reducing agent and applied on viscose fabric surface by in situ treatment 566 
[114]. Investigating the textile properties of viscose fabric, we observed that chitosan- SNPs 567 
treated fabrics showed excellent antibacterial properties while maintaining fair textile properties. 568 
In another study the authors investigated chitosan encapsulated poly(lactic acid) nanosphere and 569 
its antibacterial activity by applying it on hydrophobic textile fabric like polyester  and 570 
subsequently on woven polyester fabric though a cross linker. Its imparted good antibacterial 571 
properties to the fabric [115].  572 
Zhu et al. [116] reported that complex coacervation methods were used to produce microcapsule 573 
containing limonene and vanillin as core material while using chitosan and Arabic gum as shell 574 
material. Tannic acid gives hardening effects to microcapsule. Sustained release pattern of active 575 
agent was obtained from the microcapsule for 7 d at 37°C. Microcapsules were grafted onto 576 
cotton fabrics using esterification reaction between microcapsule and the citric acid which are 577 
followed by thermo-fixation and curing using citric acid as a nontoxic cross linker. These 578 
microcapsules showed effective action against bacteria after incorporation onto fabrics. 579 
Fabrication of active agent allows its  loading for finishing purpose or using on textile surface for 580 
dressing purpose in the form of films that are mainly useful for wounds healing and the treatment 581 
of skin diseases including skin injuries [117] . 582 
Son et al. [118] reported that pad dry cure method was used for fixing vitamin E microcapsule on 583 
dyed cotton knit. Natural indigo was used as dying agent for cotton knit and treated with 584 
microcapsules containing vitamin E including softener agent. SEM analysis confirmed the 585 
microcapsules fixation on cotton fibres. Vitamin E concentration gradually decreased with time 586 
as confirmed by LC-MS. Softness improved due to the softener, but air permeability decreased. 587 
This was a reliable method for durability and colour stability for the treated fabrics. Turkoğlu et 588 
al. [119] reported that complex coacervation technique were used to prepare microcapsule 589 
containing vitamin E which was implemented on cotton fabric using the  padding method. The 590 
capsule average diameter was 280nm. The small size alpha tocopherol made its incorporation 591 
into fibre gaps easier. Most of the capsules were found attached to fabrics even after several 592 
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washings. Sequential studies carried out on fabric containing alpha tocopherol showed that it 593 
remained attach to the fibre gaps providing considerable antioxidant activity which was essential 594 
for the maintenance of the fabric integrity. 595 
3.2 Applications in paper industry 596 
Chitosan has a great potential for pulp and paper industry. In paper industry, the surface of paper 597 
is treated with a 1% solution of chitosan to increase its folding endurance and bursting strength 598 
while the brightness of paper is maintained [120]. With the development coloured photocopying, 599 
high quality fibres are required for papers. The treatment of fibre with 0.5% solution of chitosan 600 
improved colour fastness of fibre. In the area of paper making industry, a chitosan layer is placed 601 
on photographic paper because of increased antistatic characteristics and increased electrostatic 602 
discharge which leads to a decrease in picture quality. The surface resistance due to these 603 
charges were increased more than 10,000 times after the treatment with chitosan solution [121]. 604 
3.3Applications in agriculture 605 
Microencapsulation can achieve controlled  release of active agents in pesticides, herbicides and 606 
insecticides [122].  In organic agriculture, microencapsulated materials are released on to plant 607 
for growth stimulation and controlled release of specific chemicals using anionic clay 608 
nanocomposites. Food products based on nanomaterials are prevented by organic food certifiers 609 
[123] . Nano-imidacloprid encapsulated material was used for controlling pests of vegetables in 610 
the field. Chitosan and alginate were used for encapsulation of SDS (sodium dodecyl sulfate) 611 
modified Ag/TiO2 imidacloprid nano-formulation. Testing was carried out on soybeans plants 612 
that were planted into soil with 3.1% dry matter content and pH 6.2. The degradation rate was 613 
monitored for plants and was faster during the first eight days and minimum after 20 days [124] . 614 
3.4 Applications in food industry 615 
Microencapsulation is usually followed by the incorporation of active food ingredient such as 616 
enzymes, cells, or other materials in small capsules. Sensitive food components are protected in 617 
microcapsules offering better food processors against nutritional loss. Microencapsulation allows 618 
the control release of the active food ingredients at specific sites at the right time giving higher 619 
functional features. The effectiveness of food additives is typically increased by the released 620 
functional moiety which broadens the application of food ingredients. Microencapsulation turned 621 
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reactive, sensitive, or volatile additives (vitamins, cultures, flavors, etc.) into a stable component 622 
of food [125]. Active ingredients incorporation into food and dairy products improves their 623 
nutritional worth. Calcium in orange juices, omega-3 fatty acids in eggs and guarana in 624 
sunflower seeds can be incorporated as active ingredient. Microencapsulation involves the 625 
formation of microcapsule containing shell material to entrap functional components as a core 626 
material with a few microns diameter capsule. Functional food components are uniformly coated 627 
with shell material to effectively separate the internal phase from surrounding material. Phase 628 
separation is important for increasing nutritional worth, masking off flavours and extending their 629 
storage time without any adverse effects on physical, chemical and functional properties. 630 
Microencapsulation is important therefore to increase the stability and storage imparting some 631 
important characteristics such as size distribution and morphology, and in vitro and in 632 
vivo release characteristics [126]. 633 
3.5 Applications in pharmaceuticals 634 
The studies showed that spherical beads of Indomethacin (anti-inflammatory drug) had been 635 
prepared by dispersing drug in chitosan solutions of sodium tripolyphosphate [127] . Spherical 636 
beads were prepared with narrow particle size distribution and high drug content allowing easier 637 
ability to fill into capsules or compress into tablets. A chitosan microsphere of ketoprofen was 638 
prepared by a multiple emulsion method. Oil in water emulsion provided an appropriate method 639 
for the fabrication of microparticles with suitable yield [128] . Chitosan derivatives are very 640 
useful in various biomedical applications as it has biocompatible properties like cell growth 641 
efficiency and blood compatibility. Grafted chitosan materials are beneficial for cardiovascular 642 
applications while chitosan membranes permeability with HEMA (2-Hydroxy ethyl 643 
methacrylate) can be used in the dialysis machine [129] . 644 
3.6. Biomedical applications 645 
Chitosan is suitable for medical application because of its unique properties described before 646 
including the presence of reactive functional groups (-NH2 and -OH), biocompatibility with the 647 
tissues, gel forming ability, high adsorption capacity, anti-bacterial, antithrombogenic, anti-648 
tumor antifungal activities and bioadhesivity [130]. It has therefore been used for the 649 
encapsulation of various drugs and their control release [65]. For instance, DNA can be 650 
encapsulated into the chitosan nanomaterial by coacervation technique and chitosan at neutral pH 651 
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protecting it from degradation by nucleases. When chitosan was crosslinked with pluronic 652 
molecules using ultraviolet radiation, a thermo-sensitive hydrogel was formed which have 653 
various potential application in medical science [131] such as growth hormones and plasmid 654 
DNA encapsulation and controlled release.  655 
Chitosan nanomaterials have also been used for in vivo molecular imaging. It can encapsulate 656 
Fe3O4 (imaging agent) for magnetic resonance imaging (MRI) and enhancing the hepatocyte 657 
targeted imaging [132]. In biomedical application chitosan Nano carrier for Cancer therapy has 658 
gained much importance and anti-cancer drugs and their release at the tumour sites has 659 
extensively been studies. He et al. [133] investigated using chitosan nanoparticles for 660 
encapsulating the anticancer drug, 5- Fluorouracil (5-FU). The chitosan encapsulated 5- FU 661 
microcapsule possess the desired laser light absorption ability and polymer hydrolysis at the 662 
tumour site effectively destroying the cancer cell using laser light. The efficiency and 663 
bioavailable of chitosan encapsulated drugs were much higher when compare with conventional 664 
drugs. This is because of chitosan’s true drug encapsulation ability and mucoadhisive property 665 
which lead to prolong interaction between drugs at the target site. Chitosan encapsulation of 666 
analgesic peptides bola-amphiphilic vesicles and its delivery across the blood–brain barrier and 667 
its prolonged analgesic activity was also reported [134]. The summery of biomedical 668 
applications of chitosan-based microcapsules is given in Table 4. 669 
Please insert Table 4 here… 670 
3.7 Application in tissue engineering  671 
Tissue engineering has emerged a new concept for the treatment of various diseases and injuries. 672 
It involves cell biology and molecular techniques with advanced materials in the regeneration of 673 
tissues. The human body has only limited capacity to repair every injured or diseased tissue 674 
mainly for skin and bone tissues. Tissue engineering technique interestingly provides some 675 
solution by regenerating new tissues replacing the disease tissues [135]. Hydrogel scaffold are 676 
used in tissue engineering where cells are encapsulated during the scaffold formation. These 677 
scaffolds provide support to cell growth and tissue development. The properties of hydrogen like 678 
swelling, mechanical properties, diffusion and degradation are usually suitable for the cell 679 
growth and would not affect the entrapped cell during the degradation process at target site. 680 
Chitosan has been considered as suitable candidate for cell encapsulation. Its properties are pH 681 
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dependent, where at acidic pH it become positively charged and water soluble while it forms 682 
solid hydrogel at pH of physiological system, where it exists as neutral and being hydrophobic. 683 
The presence of several amino and hydroxyl groups on chitosan facilitate its chemical 684 
modification. Water solubility of chitosan at physiological pH can be enhanced by grafting with 685 
methacrylic acid. In a previous study chitosan was grafted with polylysine to enhance 686 
microenvironment for the neural cell growth [136]. 687 
3.8 Environmental applications 688 
Wastewater generation and treatment is an important serious environmental issue particularly 689 
those generated by the textile, paper, leather and printing industries which contain significant 690 
heavy metal ions and dyes. To, date several techniques like biodegradation, coagulation, ion 691 
exchange, membrane filtration and adsorption have been used to eradicate water pollutants. In 692 
recent days chitosan-based composites have been used for wastewater treatment. Bagavathy and 693 
coworkers [137] encapsulated zinc oxide (ZnO) nanoparticle with Chitosan for dye adsorption 694 
from waste water. They investigated the adsorption of dye at different parameters and observed 695 
excellent removal efficiency. They also investigated the antibacterial efficiency of encapsulated 696 
material against Gram-positive and Gram negative bacterial and observed that chitosan 697 
effectively inhibited their proliferation. Global warming is a serious threat to the environment 698 
and extensive of petroleum in automobiles and industries making this issue wors [138]. Biofuels 699 
like ethanol and biodiesel can be a better alternative as they do not produce toxic gases like 700 
sulfer oxides upon burning. Immobilization of lipase by chitosan encapsulation for biodiesel 701 
production is gaining much attention because of the ecofriendly nature of biodiesel [139]. 702 
3.9 Critical analysis 703 
Due to excellent biocompatibility nontoxicity, antibacterial and mucoadhesive properties 704 
chitosan polymer has attracted much interest and developed potential applications in various 705 
fields specially drug delivery, tissue engineering, biosensor, would healing, bioimaging, 706 
diagnostics, gene therapy, food technology and environmental technology as encapsulating 707 
material for active ingredients. Chitosan is a biological compactible and chemically (-OH and -708 
NH2) versatile coating material. Owing to the superior properties of chitosan polymer over the 709 
other polysaccharides it not only increases the shelf life of encapsulated drugs by protecting them 710 
from harsh environment but also control their release rate. Chemically chitosan can be modified 711 
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using different crosslinking agents as describes earlier which help in control release mechanism 712 
of the drug especially anticancer drug doxorubicin release. Most of the drugs fail at clinical 713 
phase due to their inability to reach the targeted sites and also due to their negative side effects.  714 
Chitosan mucoadhesive property has provided a promising solution of this issue by targeting 715 
drug delivery system in which drugs are released only at the action sites. Chitosan has the ability 716 
to encapsulate several kinds of anticancer drugs such as PTX, curcumin, DOX, 6-717 
Mercaptopurine, Vincristine, ADR, 5-FU among others, and deliver only them to the targeted 718 
tumour sites. Apart from these scientists in the recent time used chitosan for organ target drug 719 
delivery system which shows that chitosan has gained much importance in medical filed. The 720 
biomaterials used for tissue engineering requires specific properties such as biocompatibility, 721 
biodegradability, mucoadhesive, antibacterial and their degradation products must not be toxic, 722 
all of which are inherent for chitosan making it ideally suited as tissue engineering material. In 723 
addition, chitosan could be easily modified into scaffolds, hydrogels, nanofiber and dendrimer 724 
with additional properties as tissue engineering biomaterial. Chitosan scaffolds possess unique 725 
property to develop 3-dimentional environment for tissue engineering and use of different cross-726 
linkers can help in degradation of shell material and drug release rate.  727 
Chitosan has proven itself and promising encapsulating material suitable for various therapeutic 728 
agents like antithrombotic, anticancer, antibiotics, anti-inflammatory, proteins, and amino acids 729 
while insuring their effective bioavailability at the target sites with an additional advantage of 730 
control release. This allowed chitosan to gain attention not only in the medical field but also for 731 
extensive applications in all fields of science. Chitosan is an antimicrobial and antioxidant due to 732 
presence of amino groups which act as scavenger of free hydroxyl radicals and high degree of 733 
deacetylation also increase antioxidant property of chitosan. due to its antimicrobial and 734 
antioxidant activity chitosan has also been used in encapsulation of various food material to 735 
protect them from sever external environments including low pH. Chitosan encapsulation also 736 
mask smell and undesirable flavour of active ingredient and enhance the shelf life of food 737 
material. The antimicrobial activity of chitosan has made it a useful polymeric material for 738 
introducing antimicrobial properties in fibres. Encapsulation of various nanoparticles and anti-739 
bacterial ingredients in chitosan and its application on fibres impart certain versatile properties 740 
such as antibacterial, mosquito repellent, durability, colour stability and fragrance finishing on 741 
fabrics.  742 
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4 Conclusions and future perspectives 743 
Encapsulation involves the development of tiny capsule containing particular core material 744 
chitosan surrounded by shell which plays an important role in the slow release of some chemical. 745 
It has application in food, agriculture, cosmetics and pharmaceutical industries such as the 746 
development of new flavours, improving oil ingredients, like omega 3, with sugar beet pectin 747 
microencapsulated to replace milk proteins and gum arabic and improving oxidative stability. 748 
Chitosan encapsulation of active ingredients protects them from the surrounding environment for 749 
a specific time. Different techniques have been developed to encapsulate drugs, oils, 750 
haemoglobin and vaccines among other ingredients as a core material using chitosan as shell 751 
material through techniques such as emulsification, spray drying and coacervation. Encapsulated 752 
materials are released by different means, involving dissolution, melting or diffusion and rupture. 753 
Encapsulation involves an art and a science where experience is important to develop the 754 
required capsules. Charge, size, molecular weight and deacetylation level of chitosan have great 755 
effects on microcapsule developments. Chitosan has been widely used due to its non-toxic, 756 
biodegradable and biocompatible characteristics and novel applications in drug delivery and 757 
tissue engineering.  Microencapsulation using chitosan has been effectively applied in the 758 
agriculture, cosmetics, food and pharmaceutical industries for encapsulating alcohols, aqueous 759 
solutions, oils and various other bioactives. Existing stimulant factors such as pH, enzyme 760 
activity, temperature, osmotic force and mechanical stress may rapidly or controllably release of 761 
drug from chitosan. In this situation, the release of encapsulated drug may control other stimulant 762 
like food constituent, water activity and microbial load. Heat stable encapsulating polymer 763 
quality will be needed in future for food industry because there is great challenge of survival of 764 
probiotics during heat treatment. Process cost and size of microcapsule must also be considered 765 
in future research. 766 
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Table 1. Physical properties of chitosan  1071 
Property  Indication  Reference 
Solubility Soluble in dilute aqueous acids, insoluble in 
water and organic solvents 
[140] 
Appearance White powder or flakes [141] 
Molecular 
weight 
Low MW- 50-190 kDa, ≥75% degree of 
deacetylation, 20-300 cPs. 
Medium MW- 190-310 kDa, 75-85% degree of 
deacetylation, 200-800 cPs. 
High MW- 310-375 kDa, >75% degree of 
deacetylation, 800-2000 cPs. 
[142] 
Colour White [141] 
Odour Odourless [143] 
Melting point It depends on molecular weight 
Approximately 290°C 
[144] 
Boiling point Neither boil nor evaporate [145] 
  1072 
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 Table 2. Biological properties of chitosan 1074 
Property Applications References 
Antioxidant Applicable in food and pharmaceutical 
industries 
[146] 
Antibacterial Effective for biomedical purpose and 
agriculture 
[147] 
Antifungal  Used as antifungal agent in food  [148] 
Antitumour Used as chemotherapeutic agent against 




nontoxic for normal 
constituent of body 




Important to stop bleeding [150] 
Immunoadjuvant  Effective to enhance immune system in human 
body 
[151] 
Wound healer and 
antiulcer agent 
Biomedical industries [152] 
Effective drug 
delivery agent 





formation for bones 




microbial cells easily 
bind to chitosan 























Table 3. Some micro-encapsulation approaches along with their advantages and disadvantages 1090 
Encapsulation 
method 
Advantages Disadvantages Reference 
Spray drying • High encapsulation 
efficiency 
• Stable encapsulated 
product 
• Cost effective 
• Applicable on industrial 
level 
• Easy to operate 
• Difficult to control 
the particle size 
• Highly sensitive at 
high temperate 
• low yield for small 
batches 
[157, 158] 
Extrusion • Prolong shelf life of 
products 
• Useful in temperature 
sensitive ingredients 
encapsulation  
• Shape of the extruded 
products can easily be 
controlled  
• Ingredients are truly 
encapsulated by wall 
material 
• Products are stable against 
oxidants 




• Microcapsule must 
be separated from 
liquid bath 





• Economically efficient 
• Microcapsule size 
distribution is controllable 







Freeze drying • Stable products under 
oxidation conditions 
• Operate at low temperature 
• Suitable technique for the 
encapsulation of 
ingredients which are 
unstable in aqueous media. 
 
• Process take too 
much time to 
complete 
• High energy input 
• Poor protection of 





Coacervation  • Useful for encapsulant of 
temperature sensitive 
actives 
• Organic solvent usage 
• Low cost 
• Applicable for large scale 
• Presence of 
coacervating 
material on the 
surface of 
microcapsules 
• Complex process 
• Low stability for 
complex 
coacervates 
• Use of toxic 





Emulsion • Small diameter of 
microcapsules 
• Live cell can be 
encapsulated 
• Both hydrophobic and 
hydrophilic active 
• Low thermal 
stability 









• Used for encapsulation of 
both water and lipid 
soluble actives 
• Control sustained release 
of encapsulated ingredients 
• Deliver encapsulated 
content to right site at right 
time 
• Ingredients can be 
delivered across the 
membrane 
• Expensive 
• Lap scale technique 
[166, 167] 
Spray cooling • Useful for encapsulation of 
temperature sensitive 
active ingredient  
• Economically more 
efficient as compare to 
spray drying  
 
• Low yield for small 
batches 
• Size of the particle 
is difficult to 
control 









• Wall possess thermal 
resistance 
• Simple process and easy to 
operate 
• Thickness of wall 
remain same for 





• High loading core (up to 
95%) 
• Resistance against harsh 
environment  
• Can be used at industrial 
level 
• Formaldehyde a 
toxic compound is 
used in this process 
Solvent 
evaporation  
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Table 4. Chitosan encapsulation of various active ingredients for medical applications 1094 





Drug delivery in 
gastrointestinal tract 
[5, 174] 







oxidation of oils 
 
[44, 175] 
Haemoglobin Emulsification Increased Oxygen 
affinity 
 active transport of 
some proteins and 
lipids  
[176] 
α-lipoic acid Spray drying Antioxidant, 
Anti-inflammatory 
[177] 







Astaxanthin Emulsification Antioxidant, 



















coacervation   
emulsification 



























































































































































Fig. 2. Different forms of microcapsules (a) microparticles (b) single walled (c) multiwalled (d) 1115 



















































































Fig. 7. Encapsulation of vitamin C in chitosan through spry drying method 1189 
